Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT07644923
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Postoperative Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bupivacaine — DRUG5 ml of 0.25% bupivacaine
- Lidocaine — DRUG5 ml of 1% lidocaine
- Thrombin — DRUG10000 units of thrombin
- Tranexamic acid — DRUG500 mg of tranexamic acid
- Aminocaproic acid — DRUG1000 mg of aminocaproic acid
Study Details
This study is a prospective randomized trial examining the effect of tranexamic acid (TXA) and aminocaproic acid (ε-Ahx) with local anesthetics and thrombin in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics. All surgical created wounds for any hand surgery will be treated in a randomized fashion with the following four arms: 1. Bupivacaine + lidocaine 2. Bupivacaine + lidocaine + thrombin 3. Bupivacaine + lidocaine + thrombin + tranexamic acid 4. Bupivacaine + lidocaine + thrombin + aminocaproic acid All are applied topically to surgical bed prior to closure of skin.
Key Dates
- Start date
- Aug 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Aug 1, 2028
- Completion
- Feb 1, 2029
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Bupivacaine + lidocaineSurgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine.
- Experimental: Bupivacaine + lidocaine + thrombinSurgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine + thrombin.
- Experimental: Bupivacaine + lidocaine + thrombin + tranexamic acidSurgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine + thrombin + tranexamic acid.
- Experimental: Bupivacaine + lidocaine + thrombin + aminocaproic acidSurgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine + thrombin + aminocaproic acid.
Primary Outcome Measure
Pre-Operative Pain [ Time Frame: Baseline (Day of Surgery) ]
Central Contacts
- Tom Calahan929-455-5826
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
Related Studies
- Rectus Sheath Block in Cardiac SurgeryRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Ketamine in Patients Undergoing TEVAR Procedures Receiving NCIPHASE2 · Recruiting · Sam Tyagi · Lexington, Kentucky
- Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic SurgeryRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce PainPHASE3 · Recruiting · University of California, San Francisco · San Francisco, California